You can now connect NyquistAI to ChatGPT by simply searching “NyquistAI” in the ChatGPT app directory and enabling the integration.
What this means
For the first time, you can combine ChatGPT's natural language interface with NyquistAI’s deep, structured FDA intelligence. NyquistAI is built on a global life sciences data platform with extensive clinical and regulatory coverage, including approved devices, clinical trials, and adverse event records. With this integration, ChatGPT can now access:
- FDA approvals (510(K), De Novo, PMA, HDE)
- Device indications and classifications
- Adverse events (MAUDE) and recalls
- Establishment registrations and listings
- Global clinical trials
- FDA guidance documents
Why this matters
FDA data is powerful, but fragmented, complex, and difficult to query efficiently. NyquistAI changes that. With the ChatGPT integration, you can now:
- Retrieve structured FDA data instantly with source-linked references
- Perform 510(k) strategy analysis and predicate research
- Analyze device safety signals and recall history
- Explore regulatory pathways and precedents
- Generate insights from previously hard-to-access datasets
Instead of manually searching multiple databases and PDFs, you can ask a question and get a grounded, traceable answer.
Getting started
- Search "NyquistAI" in the ChatGPT app directory
- Connect your account
- Start asking questions
Already have a NyquistAI account? You can log in immediately. New to NyquistAI? You can sign up for free and start exploring.
What's next
We believe this is just the beginning. By combining generative AI with authoritative regulatory data, we're enabling faster analysis, better decisions, and entirely new workflows across the medical device ecosystem.
If you work with FDA data, this will fundamentally change how you operate.